We are focused on the development of novel therapeutics that target cellular senescence and telomerase. Our approach is based on integrating within a bioinformatic framework a wide variety of external and in-house data sources with high content screening
Professor Nicol Keith obtained his undergraduate training in genetics at Edinburgh University before undertaking his PhD studies at the CRUK Beatson Institute for Cancer Research in Glasgow. After post-doctoral research in areas related to cancer drug resistance, he established his research program in the Department of Medical Oncology at Glasgow University. In 2004 he became Professor of Molecular Oncology at the Centre for Oncology & Applied Pharmacology of Glasgow University.